Provectus Biopharmaceutica OTC Stock Forecast - Daily Balance Of Power
PVCTDelisted Stock | USD 0.11 0.00 0.00% |
Provectus OTC Stock Forecast is based on your current time horizon.
Provectus |
Check Provectus Biopharmaceutica Volatility | Backtest Provectus Biopharmaceutica | Trend Details |
Provectus Biopharmaceutica Trading Date Momentum
On April 26 2023 Provectus Biopharmaceuticals was traded for 0.14 at the closing time. The top price for the day was 0.14 and the lowest listed price was 0.14 . The trading volume for the day was 97.4 K. The trading history from April 26, 2023 did not cause price change. The trading delta at closing time against the current closing price is 7.14% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Provectus Biopharmaceutica to competition
View Provectus Biopharmaceutica Related Equities
Risk & Return | Correlation |
Provectus Biopharmaceutica Market Strength Events
Market strength indicators help investors to evaluate how Provectus Biopharmaceutica otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Provectus Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying Provectus Biopharmaceutica otc stock market strength indicators, traders can identify Provectus Biopharmaceuticals entry and exit signals to maximize returns.
Provectus Biopharmaceutica Risk Indicators
The analysis of Provectus Biopharmaceutica's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Provectus Biopharmaceutica's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting provectus otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 3.49 | |||
Standard Deviation | 5.71 | |||
Variance | 32.57 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Provectus Biopharmaceutica information on this page should be used as a complementary analysis to other Provectus Biopharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Provectus OTC Stock
If you are still planning to invest in Provectus Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Provectus Biopharmaceutica's history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |